Palisade Bio, Inc.
PALI
$0.7556
-$0.0207-2.67%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -17.38% | -7.79% | -5.43% | -8.81% | 13.74% |
| Total Depreciation and Amortization | -25.00% | -50.00% | -40.00% | 33.33% | 33.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.53% | 32.70% | 1,161.00% | 183.97% | 316.15% |
| Change in Net Operating Assets | 247.75% | -7.05% | -35.09% | 593.28% | -68.00% |
| Cash from Operations | -9.52% | -7.40% | -0.13% | 17.79% | 16.67% |
| Capital Expenditure | -- | 100.00% | 100.00% | 60.00% | 60.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 100.00% | 100.00% | 60.00% | 60.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -8.95% | 33.27% | 38.47% | 41.72% | 50.51% |
| Issuance of Common Stock | -10.19% | -54.81% | -67.37% | -54.87% | -26.87% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -48.95% | 1.39% | 31.56% | 49.52% | 1.59% |
| Cash from Financing | -14.34% | -59.44% | -70.07% | -55.67% | -26.69% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5,428.57% | -648.00% | -144.21% | -130.38% | -97.40% |